Atea Pharmaceuticals, Inc. ( AVIR) - Stock Earnings
AVIR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
AVIR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -42.0 million USD | — USD |
| 2025Q4 | -44.9 million USD | — USD |
| 2026Q1 | -45.4 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AVIR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -136.0 million USD | — USD |
| 2024 | -168.4 million USD | — USD |
| 2025 | -158.3 million USD | — USD |
| 2026 Est. | — | — |
AVIR
Price: $4.73
52 week price:
Earnings Per Share: -2.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 884000
Ebitda: -17.0 millionMarket Capitalization: 395.3 million